Home › Oral Cancer › Wisconsin › Eau Claire
Oral Cancer clinical trials in Eau Claire, WI
3 studies for Oral Cancer are looking for participants at sites in and around Eau Claire (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RecruitingPhase 3
- Marshfield Medical Center-EC Cancer Center, Eau Claire
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- Marshfield Medical Center-EC Cancer Center, Eau Claire
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RecruitingPhase 2
- Marshfield Medical Center-EC Cancer Center, Eau Claire
About Oral Cancer
Oral cancer can form in the mouth or throat but usually begins in the tongue and floor of the mouth. Read about the common oral cancer symptoms.
More about Oral Cancer on MedlinePlus
Oral Cancer trials in other cities
- Atlanta, GA9 studies
- St. Louis, MO8 studies
- Chicago, IL8 studies
- New York City, NY8 studies
- Durham, NC7 studies
- Houston, TX7 studies
- Kansas City, MO7 studies
- Milwaukee, WI7 studies
- Portland, OR7 studies
- Pittsburgh, PA7 studies
- Ann Arbor, MI7 studies
- Richmond, VA7 studies
Other studies in Eau Claire
- Lung Cancer8 studies
- Non-Small Cell Lung Cancer7 studies
- Breast Cancer5 studies
- Prostate Cancer5 studies
- Pancreatic Cancer4 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Multiple Myeloma3 studies
- Diffuse Large B-Cell Lymphoma3 studies
- Esophageal Adenocarcinoma3 studies
- Colorectal Cancer3 studies
- Melanoma3 studies
- Hypopharyngeal Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.